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AbstractDespite developments in therapeutic and diagnostic technologies, the global burden of atherosclerotic coronary artery disease is increasing. Intravascular imaging has become an invaluable adjunct to percutaneous coronary intervention. Optical coherence tomography (OCT) is a catheter based invasive imaging system that uses light instead of ultrasound to produce high resolution in vivo images of coronary arteries and deployed stents. The technical aspects of intracoronary image acquisition, advantages, disadvantages of use and current applications of OCT in coronary atherosclerosis are discussed.
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IntroductionDespite advances in therapeutic and diagnostic technologies, ischaemic heart disease remains a global leading cause of death 
[1]. Most cases result from atherosclerosis, an inflammatory 
and fibro-proliferative process resulting in activation of growth factors, vasoregulatory mechanisms and cytokines resulting in intimal thickening and subsequent endoluminal obstruction [2]. More sophisticated interventional techniques have been adopted to combat the increasing burden of atherosclerosis, including 
intravascular ultrasound (IVUS), fractional flow reserve (FFR) and more recently, optical coherence tomography (OCT). This 
paper provides an overview of the principles and current uses of OCT in diagnosing and guiding the treatment of atherosclerotic coronary artery disease.
Principles of optical coherence tomographyIntravascular OCT provides a method of obtaining cross-
sectional tomographic vascular imaging with definition that is superior to other currently available modalities. It acts as an 
optical analogue of IVUS, where ultrasound is replaced by light 
that is reflected or back-scattered from internal structures within tissue. This ‘echo time delay’ produces a measurable signal 
intensity or magnitude. As the speed of light does not allow direct measurement of the echo time delay, interferometric techniques 
are employed to analyse the reflected light signal. Two main technologies exist to create OCT images, time domain (TD-OCT) and Fourier or frequency domain (FD-OCT). While TD-OCT uses a moving mirror as its reference arm and a broadband light source, 
FD-OCT uses a fixed mirror with a variable frequency light source 
allowing simultaneous detection of reflections from all echo time 
delays [3]. This allows faster image acquisition rates, improved 
signal-to-noise ratio with subsequent higher quality imaging, making FD-OCT the imaging mode of preference [4]. By utilising 
this ultrafast frequency swept near-infrared light source to image the vessel, FD-OCT is able to gain axial resolutions in the region of 10 to 15µm and lateral resolutions of 20 to 90µm. The rotating 
fibre-optic system creates a detailed tissue image with a ten-fold 
greater resolution than that achieved with IVUS [5-7], due to the 
shorter wavelength (1280-1350nm range) of the imaging light 
compared with ultrasound. However, the shorter wavelength 
limits tissue penetration to 1 to 3mm as compared with 4 to 8mm 
achieved with IVUS, with the exception of calcified lesions in 
which ultrasound has a limited penetration [8].Due to the high attenuation of light by red blood cells, 
effective OCT requires the clearing or flushing of blood from the 
lumen prior to imaging the desired segment of vessel. The slow acquisition speed of TD-OCT requires proximal balloon occlusion 
of the coronary of interest, with subsequent flushing of the artery 
to remove blood from the field of view. This limits its widespread adoption because of prolonged intravascular occlusion potentiating the risk of coronary damage and myocardial ischaemia. In FD-OCT, a greater frame rate is achieved because 
the swept source laser can be focussed quicker than the reference mirror can be moved in TD-OCT. Therefore, comprehensive volumetric microscopy of the vessel can be safely performed 
with the intra-arterial flushing of blood with a 10-15ml bolus of crystalloid solution, usually radio contrast, obviating the need for balloon occlusion of the vessel [9].
OCT in coronary atherosclerosis, percutaneous 
coronary intervention and plaque characterisation Both TD and FD-OCT are deemed safe in assessing 
atherosclerotic plaque characteristics, as well as guiding percutaneous coronary intervention (PCI) [10-13]. The high 
definition of OCT imaging allows all aspects of plaque morphology 
to be accurately delineated including fibrous tissue, lipid 
accumulation and calcific deposition [6,14]. A large proportion of acute coronary events arise from sudden luminal obstruction caused by thrombosis as a result of plaque rupture or erosion. Our current understanding of 
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vulnerable plaque biology suggests that approximately 80% of 
significant plaque rupture occurs within inflamed thin-capped 
fibroatheromas (TCFA) [15]. It is accepted that TCFA comprise of 
a thin fibrous cap less than 65µm in diameter, overlying a large necrotic lipid pool (>2 quadrants of the cross-sectional image), 
with associated inflammatory cell cap infiltration [16]. Studies using virtual histology IVUS have previously determined TCFA as a predictor of major adverse cardiovascular events (MACE) 
[17,18]. As OCT provides superior in vivo characterisation of plaque morphology, identifying TCFA may prospectively identify 
the most vulnerable lesions and therefore influence prognosis. This has been validated in clinical studies comparing OCT 
with IVUS in acute coronary cohorts [16,19], particularly as a 
rupture-prone fibrous cap less than 65 microns is well under the resolution capacity of IVUS. In vivo and post mortem studies have also corroborated the ability of OCT to accurately detect TCFA, especially in identifying its increased incidence in myocardial infarction [20-22]. Furthermore, OCT has been successfully used to examine the role of pharmacological interventions on plaque anatomy and stability [23-25].
 Figure 1: Frequency domain-optical coherence tomography 
imaging of atherosclerotic arteries showing A) fibrotic plaque, B) 
fibrocalcific plaque, C) lipid-rich fibroatheroma and D) a thin-cap 
(arrow) fibroatheroma. Lipid/calcification arcs and fibrous cap thickness are marked.In normal vessels, the coronary artery appears as a three 
layered structure with OCT. A dark band denotes the low signal 
muscular media layer between the internal elastic lamina and external elastic lamina. Due to its limited tissue penetration, 
however, OCT is not well suited to assess significant vascular remodelling and total plaque volume. Fibrous plaques tend 
to appear as high signal homogenous regions with high levels 
of back-scatter. Calcifications within plaques are identified 
by the presence of well circumscribed, low back-scattering 
heterogenous areas [6,8,14,19]. Lipid pools, in contrast, are 
less well delineated than calcification and appear as diffusely 
bordered, low signal areas with more heterogenous back-
scattering than fibrous plaques [6,8,14,19]. In reality, an overlying 
signal-rich band usually corresponds to a fibrous cap of varying 
thickness (See Figure 1). Thrombi are identified by the protrusion of a mass into the vessel lumen discontinuous from the arterial 
wall and may be found in culprit lesions of patients with acute 
coronary syndromes [6,8,14,19,26,27]. In the early stages of thrombogenesis, a rapidly organising thrombus traps blood cell 
constituents and on maturation, it becomes more fibrous and 
less cellular, turning from ‘red’ to ‘white’. OCT has been shown 
to accurately distinguish between red and white thrombi, and may therefore aid in determining optimal therapeutic strategy [26]. Red thrombi, consisting mainly of signal attenuating red 
cells, are characterised by high back-scattering protrusions with 
signal-free shadowing. White thrombi, comprising predominantly 
of platelets and white cells, appear as signal-rich, low back-scattering projections into the vessel lumen26. Plaque ulceration 
or rupture can be detected by OCT as a ruptured fibrous cap that 
connects the lumen with the lipid pool. These may or may not be 
associated with superimposed thrombus. (See Table)
Table 1: Image characteristics of optical coherence tomography with different plaque morphologies.
Tissue Characteristics OCT characteristics
Fibrous HomogenousHigh reflectivity
Low attenuation
Lipid
Diffuse edges
High reflectivityHigh attenuation
Calcific
Sharp well defined edges
Low reflectivity (compared to IVUS)
Low attenuation
Red thrombus Mass protruding into vessel lumenMedium reflectivityHigh attenuation
White thrombus Luminal protrusionMedium reflectivity
Low attenuationStents: Metallic High reflectivityHigh attenuation
Bioresorbable Low reflectivity (if residual polymer present)
Low attenuation(IVUS - intravascular ultrasound)In addition to plaque characterisation, OCT has been used to optimise and guide PCI by providing a clear depiction of the 
boundaries between vessel, lumen and metallic stent struts. The near infra-red OCT light does not penetrate metal, hence stent 
struts are visualized as linear structures with strong surface 
reflection and typical dorsal shadowing [28]. Earlier papers allude to OCT outperforming IVUS in detecting spontaneous and PCI-induced dissection, tissue prolapse and incomplete stent 
apposition, all of which have been implicated in acute as well as late 
stent thrombosis [12,29,30]. Limited outcome data also exists to 
show OCT-guided PCI as superior to angiography alone [31]. This 
unrivalled endovascular resolution has allowed assessment of the 
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vascular response at individual stent strut level following device deployment. Hence, numerous in-vivo OCT studies have exploited its capability to study factors related to the prognosis of stent-implanted lesions, including neointimal hyperplasia, stent strut coverage, stent malapposition and in-stent neoatherosclerosis [32-34]. 
Technical drawbacks to OCT, in addition to limited tissue depth penetration, include inability to image plaques located at the very 
ostium of the coronaries, particularly with TD-OCT where balloon occlusion is required. Moreover, distinguishing different plaque morphology relies on operator experience and is subject to an 
element of inter-observer variability, analogous to grey-scale with IVUS [35]. 
ConclusionIntracoronary OCT currently provides unparalleled high 
resolution anatomical data which the interventional cardiologist 
can use to optimise treatment. It allows detailed structural analysis of atherosclerotic plaques and helps characterise the vascular 
healing process post PCI. However, there are still limitations with this technique and alternative imaging modalities such as IVUS still have a role in plaque delineation and PCI optimisation. Future 
developments such as micro-OCT will offer spatial resolution that is ten times that of FD-OCT, permitting sub-cellular analysis of the atherosclerotic process and improved diagnostic capabilities for the prospective prevention of coronary artery disease. Potential 
research combining doppler-like signal detection with OCT will 
allow integration of physiological and anatomical assessment using a single device. 
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